DEA Reviews Application from LTS for Controlled Substance Imports
Published Date: 3/7/2025
Notice
Summary
LTS Therapy Systems, LLC wants to become an official importer of certain controlled substances. This means they’ll be allowed to bring in specific drugs that are carefully regulated. If approved, this could affect businesses and patients relying on these substances, with no immediate cost changes announced.
Analyzed Economic Effects
2 provisions identified: 0 benefits, 0 costs, 2 mixed.
Company Applied to Import Controlled Drugs
LTS Therapy Systems, LLC has applied to be registered as an importer of basic class(es) of controlled substances. If approved, the company would be allowed to bring in specific DEA-controlled drugs for use in the U.S.
Potential Supply Effects for Patients and Businesses
The notice says that if LTS Therapy Systems is approved as an importer, this could affect businesses and patients who rely on these controlled substances. The notice also states there are no immediate cost changes announced.
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Take It Personal
Get Your Personalized Policy View
Start a Free Government Policy Watch to see how policy affects your household, then upgrade to PRIA Full Coverage for year-round monitoring.
Already have an account? Sign in